Kumar Rashmi — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

Kumar Rashmi has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $67K.

Profile

Kumar Rashmi is identified in the 2026-06-05 SEC filing as a Director of Myriad Genetics, Inc. The filing confirms a board seat but does not disclose additional biographical details within the SEC context available. Public records do not (based on the provided filing) reveal education, prior roles, or committee assignments for this individual.

Board memberships

• Myriad Genetics, Inc.

Awards & honors

• Board membership: Director at Myriad Genetics, Inc. as of 2026-06-05

Recent Transactions

Companies — Last 90 Days

• MYRIAD GENETICS INC (MYGN) — 2 filings, last 2026-06-09

Frequently Asked Questions

Who is Kumar Rashmi?

Kumar Rashmi is identified in the 2026-06-05 SEC filing as a Director of Myriad Genetics, Inc. The filing confirms a board seat but does not disclose additional biographical details within the SEC context available. Public records do not (based on the provided filing) reveal education, prior roles, or committee assignments for this individual.…

How many SEC Form 4 filings has Kumar Rashmi submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Has Kumar Rashmi been buying or selling stock?

Recorded transactions: 0 open-market purchases () and 1 open-market sales ($67K) across all tracked filings.

Where can I see all of Kumar Rashmi's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week